During the recent session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 1.57 million, with the beta value of the company hitting 2.15. At the last check today, the stock’s price was $0.13, reflecting an intraday loss of -8.29% or -$0.01. The company’s market capitalization is $12.75M, and the average intraday trading volume over the past 10 days was 4.83 million shares, and the average trade volume was 11.73 million shares over the past three months.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Conduit Pharmaceuticals Inc (CDT) registered a -8.29% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -8.29% in intraday trading to $0.13, hitting a weekly high. The stock’s 5-day price performance is -19.52%, and it has moved by -42.63% in 30 days. Based on these gigs, the overall price performance for the year is -98.77%. The short interest in Conduit Pharmaceuticals Inc (NASDAQ:CDT) is 6.81 million shares and it means that shorts have 0.23 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CDT Dividends
Conduit Pharmaceuticals Inc is due to release its next quarterly earnings in September. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
Conduit Pharmaceuticals Inc insiders own 76.00% of total outstanding shares while institutional holders control 3.12%, with the float percentage being 13.01%.
Also, the Mutual Funds coming in first place with the largest holdings of Conduit Pharmaceuticals Inc (CDT) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . Data provided on Mar 31, 2024 indicates that Vanguard Extended Market Index Fund owns about 202.93 shares. This amounts to just over 0.21 percent of the company’s overall shares, with a $26949.0 market value. The same data shows that the other fund manager holds slightly less at 54.39, or about 0.06% of the stock, which is worth about $7223.0.
